ResearcherRadboud University Medical CenterActive in the last 2 years
T. H. Perik
Matched on ORCID iD 0000-0002-4194-787X; OpenAlex author ID A5050207262. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-026-05420-5↗
- Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.pan.2025.01.011↗
- Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16030577↗
- Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1007/s00261-021-03190-w↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- John J. Hermans · 4 shared papers, 2022–2026 · strength 1.06
- Paper Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenoc… DOI 10.1007/s00261-026-05420-5↗
- Paper Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16030577↗
- Paper Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in pa… DOI 10.1016/j.pan.2025.01.011↗
- HenkJan J. Huisman · 3 shared papers, 2022–2026 · strength 0.81
- Paper Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenoc… DOI 10.1007/s00261-026-05420-5↗
- Paper Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16030577↗
- Paper Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review. DOI 10.1007/s00261-021-03190-w↗
- Natália Alves · 2 shared papers, 2024–2026 · strength 0.63
- Paper Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenoc… DOI 10.1007/s00261-026-05420-5↗
- Paper Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16030577↗
- Geke Litjens · 2 shared papers, 2025–2026 · strength 0.56
- Paper Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenoc… DOI 10.1007/s00261-026-05420-5↗
- Paper Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in pa… DOI 10.1016/j.pan.2025.01.011↗
- Erwin J. M. van Geenen · 1 shared paper, 2026 · strength 0.32
- Martijn W.J. Stommel · 1 shared paper, 2026 · strength 0.32
- Fons van der Sommen · 1 shared paper, 2025 · strength 0.25
- Peter Derk Siersema · 1 shared paper, 2025 · strength 0.25
- Mike J.P. de Jong · 1 shared paper, 2025 · strength 0.25
- Erik H.J.G. Aarntzen · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.